BIOC logo

Biocept (BIOC) CAPEX

Annual CAPEX

$807.00 K
-$765.00 K-48.66%

December 31, 2022

Summary

Performance

1-Year Change

-48.66%

3-Year Change

+9.75%

5-Year Change

-42.37%

15-Year Change

-42.37%

BIOC CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.07%
BIOC annual capital expenditures is higher than 32.07% of companies in Healthcare sector

High & Low

All-time High

$1.57 M
BIOC annual capital expenditures is currently -48.66% below its historical high of $1.57 million

3-Year Low

$807.00 K
BIOC annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Annual FCF

-$14.10 M
BIOC annual free cash flow is -$14.10 million

Annual CFO

-$13.29 M
BIOC annual cash flow from operations is -$13.29 million

Annual CFI

-$807.00 K
BIOC annual cash flow from investing activities is -$807.00 thousand

Annual CFF

-$1.87 M
BIOC annual cash flow from financing activities is -$1.87 million

Quarterly CAPEX

$97.00 K
+$6000.00+6.59%

June 30, 2023

Summary

Performance

3-Month Change

+6.59%

1-Year Change

-55.3%

3-Year Change

+470.59%

5-Year Change

+427.17%

BIOC Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.43%
BIOC quarterly capital expenditures is higher than 31.43% of companies in Healthcare sector

High & Low

All-time High

$802.70 K
BIOC quarterly capital expenditures is currently -87.92% below its historical high of $802.70 thousand

3-Year Low

$91.00 K
BIOC quarterly capital expenditures is currently +6.59% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Quarterly FCF

-$3.18 M
BIOC quarterly free cash flow is -$3.18 million

Quarterly CFO

-$3.09 M
BIOC quarterly cash flow from operations is -$3.09 million

Quarterly CFI

-$22.00 K
BIOC quarterly cash flow from investing activities is -$22.00 thousand

Quarterly CFF

$2.97 M
BIOC quarterly cash flow from financing activities is $2.97 million

TTM CAPEX

$680.00 K
-$120.00 K-15.00%

June 30, 2023

Summary

Performance

3-Month Change

-15%

1-Year Change

-35.55%

3-Year Change

-0.63%

5-Year Change

-7.52%

BIOC TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.48%
BIOC TTM capital expenditures is higher than 32.48% of companies in Healthcare sector

High & Low

All-time High

$1.78 M
BIOC TTM capital expenditures is currently -61.90% below its historical high of $1.78 million

3-Year Low

$680.00 K
BIOC TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

TTM FCF

-$18.28 M
BIOC TTM free cash flow is -$18.28 million

TTM CFO

-$17.60 M
BIOC TTM cash flow from operations is -$17.60 million

TTM CFI

-$605.00 K
BIOC TTM cash flow from investing activities is -$605.00 thousand

TTM CFF

$1.91 M
BIOC TTM cash flow from financing activities is $1.91 million

BIOC CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-48.7%-55.3%-35.5%
3 y3 years+9.8%+470.6%-0.6%
5 y5 years-42.4%+427.2%-7.5%

BIOC CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.7%at low-83.6%+6.6%-56.7%at low
5 y5-year-48.7%+9.8%-87.9%+470.6%-61.9%+35.5%
alltimeall time-48.7%>+9999.0%-87.9%-100.0%-61.9%>+9999.0%

Biocept CAPEX History

DateAnnualQuarterlyTTM
Jun 2023
-
$97.00 K(+6.6%)
$680.00 K(-15.0%)
Mar 2023
-
$91.00 K(-33.1%)
$800.00 K(-0.9%)
Dec 2022
$807.00 K(-48.7%)
$136.00 K(-61.8%)
$807.00 K(-36.0%)
Sep 2022
-
$356.00 K(+64.1%)
$1.26 M(+19.5%)
Jun 2022
-
$217.00 K(+121.4%)
$1.05 M(+10.1%)
Mar 2022
-
$98.00 K(-83.4%)
$958.00 K(-39.1%)
Dec 2021
$1.57 M(+81.3%)
$590.00 K(+293.3%)
$1.57 M(-11.9%)
Sep 2021
-
$150.00 K(+25.0%)
$1.78 M(+7.3%)
Jun 2021
-
$120.00 K(-83.1%)
$1.66 M(+6.6%)
Mar 2021
-
$712.00 K(-11.3%)
$1.56 M(+80.0%)
Dec 2020
$867.00 K(+17.9%)
$802.70 K(+2677.5%)
$867.10 K(+72.8%)
Sep 2020
-
$28.90 K(+70.0%)
$501.80 K(-26.7%)
Jun 2020
-
$17.00 K(-8.1%)
$684.30 K(-5.1%)
Mar 2020
-
$18.50 K(-95.8%)
$720.90 K(-2.0%)
Dec 2019
$735.30 K(+406.1%)
$437.40 K(+106.9%)
$735.30 K(+146.8%)
Sep 2019
-
$211.40 K(+294.4%)
$297.90 K(+86.9%)
Jun 2019
-
$53.60 K(+62.9%)
$159.40 K(+28.3%)
Mar 2019
-
$32.90 K(>+9900.0%)
$124.20 K(-14.5%)
Dec 2018
$145.30 K
$0.00(-100.0%)
$145.30 K(-70.3%)
Sep 2018
-
$72.90 K(+296.2%)
$489.90 K(-48.2%)
Jun 2018
-
$18.40 K(-65.9%)
$945.10 K(-28.8%)
DateAnnualQuarterlyTTM
Mar 2018
-
$54.00 K(-84.3%)
$1.33 M(-5.2%)
Dec 2017
$1.40 M(+190.4%)
$344.60 K(-34.7%)
$1.40 M(+22.1%)
Sep 2017
-
$528.10 K(+32.0%)
$1.15 M(+67.2%)
Jun 2017
-
$400.20 K(+214.6%)
$685.60 K(+32.1%)
Mar 2017
-
$127.20 K(+39.9%)
$519.00 K(+7.7%)
Dec 2016
$482.10 K(+191.8%)
$90.90 K(+35.1%)
$482.10 K(+10.2%)
Sep 2016
-
$67.30 K(-71.2%)
$437.50 K(+5.1%)
Jun 2016
-
$233.60 K(+158.7%)
$416.40 K(+80.7%)
Mar 2016
-
$90.30 K(+95.0%)
$230.40 K(+39.5%)
Dec 2015
$165.20 K(-58.2%)
$46.30 K(+0.2%)
$165.20 K(-47.1%)
Sep 2015
-
$46.20 K(-2.9%)
$312.00 K(-32.4%)
Jun 2015
-
$47.60 K(+89.6%)
$461.30 K(+9.8%)
Mar 2015
-
$25.10 K(-87.0%)
$420.00 K(+6.4%)
Dec 2014
$394.90 K(>+9900.0%)
$193.10 K(-1.2%)
$394.90 K(+95.7%)
Sep 2014
-
$195.50 K(+3003.2%)
$201.80 K(+3103.2%)
Jun 2014
-
$6300.00(>+9900.0%)
$6300.00(+800.0%)
Dec 2013
$700.00(-91.3%)
$0.00(0.0%)
$700.00(0.0%)
Sep 2013
-
$0.00(-100.0%)
$700.00(0.0%)
Jun 2013
-
$700.00
$700.00
Dec 2012
$8000.00(-97.3%)
-
-
Dec 2011
$295.40 K
-
-

FAQ

  • What is Biocept annual capital expenditures?
  • What is the all time high annual CAPEX for Biocept?
  • What is Biocept annual CAPEX year-on-year change?
  • What is Biocept quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Biocept?
  • What is Biocept quarterly CAPEX year-on-year change?
  • What is Biocept TTM capital expenditures?
  • What is the all time high TTM CAPEX for Biocept?
  • What is Biocept TTM CAPEX year-on-year change?

What is Biocept annual capital expenditures?

The current annual CAPEX of BIOC is $807.00 K

What is the all time high annual CAPEX for Biocept?

Biocept all-time high annual capital expenditures is $1.57 M

What is Biocept annual CAPEX year-on-year change?

Over the past year, BIOC annual capital expenditures has changed by -$765.00 K (-48.66%)

What is Biocept quarterly capital expenditures?

The current quarterly CAPEX of BIOC is $97.00 K

What is the all time high quarterly CAPEX for Biocept?

Biocept all-time high quarterly capital expenditures is $802.70 K

What is Biocept quarterly CAPEX year-on-year change?

Over the past year, BIOC quarterly capital expenditures has changed by -$120.00 K (-55.30%)

What is Biocept TTM capital expenditures?

The current TTM CAPEX of BIOC is $680.00 K

What is the all time high TTM CAPEX for Biocept?

Biocept all-time high TTM capital expenditures is $1.78 M

What is Biocept TTM CAPEX year-on-year change?

Over the past year, BIOC TTM capital expenditures has changed by -$375.00 K (-35.55%)